首頁 > 市場調查報告書 > 醫療設備

導管

血栓切除器材市場規模、佔有率和成長分析（按技術、類型、用途、應用和地區分類）—產業預測（2026-2033 年）

市場調查報告書

商品編碼

1898185

血栓切除器材市場規模、佔有率和成長分析（按技術、類型、用途、應用和地區分類）—產業預測（2026-2033 年）

Thrombectomy Devices Market Size, Share, and Growth Analysis, By Technology (Mechanical Thrombectomy, Aspiration Thrombectomy), By Type (Automated Devices, Manual Devices), By Utility, By Application, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月26日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，全球血栓切除器材市場規模將達到 20.1 億美元，到 2025 年將達到 21.3 億美元，到 2033 年將達到 34.5 億美元，預測期（2026-2033 年）的複合年成長率為 6.2%。

血栓切除器械市場正經歷強勁成長，其促進因素包括心血管疾病盛行率的上升、技術進步以及人口老化。微創器械和血栓摘取支架等領域的創新顯著改善了患者的治療效果，簡化了手術流程，減少了併發症，並加快了康復速度。隨著製造商將研發投入優先，以開發有效的解決方案，這種快速的創新成長至關重要。此外，老年人罹患心血管疾病和血栓症的風險更高，這進一步推動了對血栓切除器械的需求。隨著老年人口的成長，對高效及時的治療方案的需求變得日益迫切，這使得血栓切除器械成為現代醫療保健策略的重要組成部分。

血栓切除器械市場促進因素

心血管疾病（如中風和心臟病）發病率的不斷上升顯著推動了血栓切除裝置的需求。隨著人口老化和久坐生活方式的日益普遍，這些健康問題的盛行率持續上升。血栓切除裝置對於快速清除血栓、恢復正常血流至關重要，在改善患者預後方面發揮關鍵作用。這些裝置在緊急情況下的有效性凸顯了其在醫療保健領域的重要性，也促使醫療機構尋求更先進的解決方案來應對心血管急症，進一步激發了人們對血栓切除裝置市場的興趣和投資。

限制血栓切除器械市場的因素

與其他醫療干預措施一樣，血栓切除器械市場也面臨血栓切除手術固有風險帶來的重大限制。潛在的併發症，例如血管損傷、出血、感染以及血栓脫落和栓塞的風險，引發了人們對安全性和有效性的擔憂。這些擔憂影響著醫療服務提供者和病患的選擇，最終影響血栓切除器械的接受度和廣泛應用。只要對潛在不良後果的擔憂持續存在，相關人員就會對這些醫療設備保持謹慎態度，這可能會阻礙市場的整體成長和發展。

血栓切除器械市場趨勢

由於缺血性中風發病率不斷上升，血栓切除器械市場正經歷顯著成長，推動了對先進醫療干預措施需求的激增。主要產業參與者正集中研發資源，致力於創新和改進產品，專注於開發抽吸裝置、血栓切除裝置和抽吸導管等先進技術，以有效治療缺血性中風。這些新一代器械具有更強大的追蹤功能、更有效率的血栓清除過程和更人性化的設計，有助於醫療專業人員提高手術效率。這種對技術創新的重視有望改善患者預後，並重塑治療模式。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Medtronic（Ireland）
Abbott（United States）
Boston Scientific（United States）
Stryker（United States）
Johnson & Johnson（United States）
Penumbra（United States）
Terumo（Japan）
Koninklijke Philips（Netherlands）
Becton, Dickinson and Company（BD）（United States）
Merit Medical Systems（United States）
Teleflex Incorporated（United States）
AngioDynamics（United States）
Edwards Lifesciences（United States）
Cerenovus（United States）
Vascular Solutions（United States）
Balt Extrusion（United States）
Acandis（Germany）

結論與建議

簡介目錄

Product Code: SQMIG35A2258

Thrombectomy Devices Market size was valued at USD 2.01 Billion in 2024 and is poised to grow from USD 2.13 Billion in 2025 to USD 3.45 Billion by 2033, growing at a CAGR of 6.2% during the forecast period (2026-2033).

The thrombectomy devices market is experiencing robust growth, driven by a combination of increasing cardiovascular disease prevalence, technological advancements, and an expanding aging population. Innovations in the field, such as minimally invasive devices and stent retriever technologies, have significantly enhanced patient outcomes and streamlined procedures, leading to reduced complications and faster recovery times. This surge in technology is pivotal as manufacturers prioritize research and development to create effective solutions. Additionally, the aging demographic is particularly vulnerable to cardiovascular issues and blood clots, escalating the demand for thrombectomy devices. As this population grows, the need for efficient and timely treatment solutions becomes increasingly crucial, positioning thrombectomy devices as an essential component of modern healthcare strategies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Thrombectomy Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Thrombectomy Devices Market Segments Analysis

Global Thrombectomy Devices Market is segmented by Technology, Type, Utility, Application and region. Based on Technology, the market is segmented into Mechanical Thrombectomy, Aspiration Thrombectomy and Rheolytic Thrombectomy. Based on Type, the market is segmented into Automated Devices and Manual Devices. Based on Utility, the market is segmented into Reusable Devices and Disposable Devices. Based on Application, the market is segmented into Peripheral Diseases, Coronary Disease and Neural Diseases. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Thrombectomy Devices Market

The rising incidence of cardiovascular diseases such as strokes and heart attacks significantly propels the demand for thrombectomy devices. With an increasingly aging population and a rise in sedentary lifestyles, the prevalence of these health conditions continues to trend upward. Thrombectomy devices are essential in swiftly removing blood clots and restoring normal blood flow, which plays a crucial role in improving patient outcomes. The effectiveness of these devices in critical situations highlights their importance in medical settings, driving further interest and investment in the thrombectomy devices market as healthcare providers seek advanced solutions for managing cardiovascular emergencies.

Restraints in the Thrombectomy Devices Market

The thrombectomy devices market faces significant restraints due to the inherent risks associated with thrombectomy procedures, much like other medical interventions. Potential complications, including vessel injury, bleeding, infection, or the risk of the clot being dislodged and causing an embolism, contribute to concerns regarding safety and efficacy. These apprehensions can affect the choices made by healthcare providers and patients, ultimately influencing the acceptance and adoption of thrombectomy devices. As concerns about potential adverse outcomes persist, they may hinder the overall growth and advancement of the market, as stakeholders remain cautious in their approach to these medical devices.

Market Trends of the Thrombectomy Devices Market

The thrombectomy devices market is experiencing significant growth driven by the rising incidence of ischemic strokes, prompting a surge in demand for advanced medical interventions. Major industry players are increasingly channeling resources into research and development to innovate and enhance product offerings, particularly focusing on sophisticated technologies such as suction devices, clot retrievers, and aspiration catheters tailored for effective ischemic stroke management. These next-generation devices are engineered with enhanced tracking capabilities, streamlined clot retrieval processes, and user-friendly designs, which facilitate improved procedural efficiency for healthcare professionals. As a result, this focus on technological advancement is poised to uplift patient outcomes and reshape treatment paradigms.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Thrombectomy Devices Market Size by Technology & CAGR (2026-2033)

Market Overview
Mechanical Thrombectomy
Aspiration Thrombectomy
Rheolytic Thrombectomy

Global Thrombectomy Devices Market Size by Type & CAGR (2026-2033)

Market Overview
Automated Devices
Manual Devices

Global Thrombectomy Devices Market Size by Utility & CAGR (2026-2033)

Market Overview
Reusable Devices
Disposable Devices

Global Thrombectomy Devices Market Size by Application & CAGR (2026-2033)

Market Overview
Peripheral Diseases
Coronary Disease
Neural Diseases

Global Thrombectomy Devices Market Size & CAGR (2026-2033)

North America (Technology, Type, Utility, Application)
- US
- Canada
Europe (Technology, Type, Utility, Application)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Technology, Type, Utility, Application)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Technology, Type, Utility, Application)
- Brazil
- Rest of Latin America
Middle East & Africa (Technology, Type, Utility, Application)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Penumbra (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Koninklijke Philips (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD) (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merit Medical Systems (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teleflex Incorporated (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AngioDynamics (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Edwards Lifesciences (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cerenovus (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vascular Solutions (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Balt Extrusion (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Acandis (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments